Ontario Institute for Cancer Research funding aims to speed the development of new drugs for some of the most common cancers

Investment in Ontario drug discovery research will help develop new cancer medicines for patients

Study points to common protein duo as a new therapeutic target for several cancer types

Unexpected mitochondria activity in leukemia cells gives opening for new treatments

Accelerating the development of new cancer drugs in Ontario

OICR funding for Ontario drug discovery projects will accelerate development of new cancer therapies